Journal Article

Twenty one years of P19 cells: what an embryonal carcinoma cell line taught us about cardiomyocyte differentiation

Marcel A.G. van der Heyden and Libert H.K. Defize

in Cardiovascular Research

Published on behalf of European Society of Cardiology

Volume 58, issue 2, pages 292-302
Published in print May 2003 | ISSN: 0008-6363
Published online May 2003 | e-ISSN: 1755-3245 | DOI: https://dx.doi.org/10.1016/S0008-6363(02)00771-X

More Like This

Show all results sharing this subject:

  • Cardiovascular Medicine

GO

Show Summary Details

Preview

Abstract

Many different stem cell types have been shown to differentiate into cardiac muscle cells in vitro but P19 embryonal carcinoma (EC) cells were one of the first examples described and have been the most extensively characterized. P19 EC cells, isolated from an experimental embryo-derived teratocarcinoma in mice, are multipotent and can differentiate into cell types of all three germ layers. Because of their capacity to form cardiomyocytes however, they have been used to dissect the role of cardiac-specific transcription factors and upstream signalling pathways in cardiac cell differentiation. Furthermore, they have shed light on unique aspects of cardiac cell physiology during heart cell differentiation, including regulation of the proteins underlying the electrical and contractile systems. Here, we review studies on different subclones of P19 cells, and what they have taught us about cardiac differentiation and physiology.

Keywords: Cell culture/isolation; Developmental biology; Gene expression; Signal transduction; Stem cells

Journal Article.  7635 words.  Illustrated.

Subjects: Cardiovascular Medicine